Previous studies have reported associations between differential DNA methylation levels in promoter regions of genes encoding metabolic enzymes—such as CYP2E1, CYP2D6, GSTP1, and NAT2—and ATDILI risk in tuberculosis patients17,18,21. The gene discussed is NAT2; the disease is tuberculosis.